Biobanking Market Size & Share, by Product (Equipment, Consumables, Service, Software); Specimen Type (Blood Products, Human Tissue, Nucleic Acids, Cell Lines, Biological Fluids); Storage Type (Manual Storage, Automated Storage); Application (Regenerative Medicine, Life Science Research, Clinical Research); End-user (Academic Institutions, Pharma & Biotech Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4602
  • Published Date: Feb 16, 2023
  • Report Format: PDF, PPT

Companies Dominating the Biobanking Landscape

top-features-companies
    • UK Biobank Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Holdings, Inc.
    • Tecan Trading AG
    • Hamilton Bonaduz AG
    • Bay Biosciences LLC.
    • ISENET USA LLC
    • ASKION GmbH
    • Promega Corporation
    • VWR International, LLC.
    • Merck KGaA

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fisher Scientific Inc. and Qatar Genome Program (QGP), a member of Qatar Foundation, partnered to speed up genomic research and clinical applications of predictive genomics in Qatar to accelerate the benefits of precision medicine across Arab populations worldwide. By combining whole genome sequencing data with an Axiom custom genotyping array for Pan-Arab populations, this partnership aims to advance scientific research and provide insights into conditions such as diabetes, cardiovascular and metabolic disorders, autism, and other genetic disorders.

  • UK Biobank Limited released the Whole Genome Sequencing (WGS) data of 200,000 UK Biobank participants for research use. Through these steps, researchers are estimated to understand the genetic factors of the disease and accelerate advanced drug discovery work.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4602
  • Published Date: Feb 16, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing instances of umbilical cord blood cell conservation are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2033.

The associated high cost of storage of specimen samples is estimated to be the growth hindering factor for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific Holdings, Inc., Tecan Trading AG, Hamilton Bonaduz AG, Bay Biosciences LLC., ISENET USA LLC, ASKION GmbH, Promega Corporation, VWR International, LLC., Merck KGaA, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, specimen type, storage type, application, end-user, and by region.

The blood products segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying